Tara E. Power
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Tara E. Power has a total of 5 co-authors. Here are the top co-authors by number of shared publications:
John W. Robinson
2 shared publicationsDawna M. Gilchrist
Medical Genetics University of Alberta Edmonton AB Canada
1 shared publicationFrancois P. Bernier
Department of Medical Genetics University of Calgary Calgary AB Canada
1 shared publicationLeora C. Swartzman
1 shared publicationPeter Bridge
Molecular Diagnostic Laboratory Alberta Children's Hospital Calgary AB Canada
1 shared publication
Latest Publications
- 1 May 2011
- Published by Elsevier in Patient Education and Counseling
- Vol. 83 (2) , 163-169
Cognitive-emotional decision making (CEDM): A framework of patient medical decision making
- 1 May 2011
- Published by Elsevier in Patient Education and Counseling
- Vol. 83 (2) , 163-169
Cognitive-emotional decision making (CEDM): A framework of patient medical decision making
- 21 April 2011
- Published by Wiley in Journal of Genetic Counseling
- Vol. 20 (3) , 249-269
Distress and Psychosocial Needs of a Heterogeneous High Risk Familial Cancer Population
In order to assess the levels of distress and psychosocial support needs of a high risk population, we undertook a study to look at both the objective and subjective levels of distress and the wants and needs of individuals from a high familial cancer risk population. Three hundred and eighteen individuals (160 affected, 158 unaffected) completed several distress and psychosocial needs questionnaires (including the Brief Symptom Inventory‐18). Sixty key informants were also surveyed about their perspective on the support needs of this population. In the largely female (90%), largely HBOC syndrome group (approximately 90%), 20% had significant levels of generalized distress, with no significant differences between affected and unaffected individuals. Generalized distress was also not significantly different as a function of mutation status. Individuals who received inconclusive test results, however, were more likely to indicate somatic symptoms of distress. Those individuals who did not have social support were more likely to be those who had never had cancer and who either had a mutation, received inconclusive test results, or were not tested. Key informants were most likely to indicate that patients need more support. These results provide evidence for the importance of establishing regular psychosocial distress screening, including a focus on somatic symptoms, in such high risk populations.
- 21 April 2011
- Published by Wiley in Journal of Genetic Counseling
- Vol. 20 (3) , 249-269
Distress and Psychosocial Needs of a Heterogeneous High Risk Familial Cancer Population
In order to assess the levels of distress and psychosocial support needs of a high risk population, we undertook a study to look at both the objective and subjective levels of distress and the wants and needs of individuals from a high familial cancer risk population. Three hundred and eighteen individuals (160 affected, 158 unaffected) completed several distress and psychosocial needs questionnaires (including the Brief Symptom Inventory‐18). Sixty key informants were also surveyed about their perspective on the support needs of this population. In the largely female (90%), largely HBOC syndrome group (approximately 90%), 20% had significant levels of generalized distress, with no significant differences between affected and unaffected individuals. Generalized distress was also not significantly different as a function of mutation status. Individuals who received inconclusive test results, however, were more likely to indicate somatic symptoms of distress. Those individuals who did not have social support were more likely to be those who had never had cancer and who either had a mutation, received inconclusive test results, or were not tested. Key informants were most likely to indicate that patients need more support. These results provide evidence for the importance of establishing regular psychosocial distress screening, including a focus on somatic symptoms, in such high risk populations.